Table 1 Baseline characteristic of the study participantsa
Variables | TB (n = 40) | TB-DM (n = 40) | p-valueb | Healty Controls (n = 20) | p-valuec | p-valued |
|---|---|---|---|---|---|---|
Sex, Male (n, %) | 29 (75.5) | 39 (97.5) | 0.0024 | 14 (70.0) | 0.466 | < 0.001 |
Age (years) | 26.6 ± 7.6 | 40.1 ± 8.8 | < 0.0001 | 32.5 ± 6.3 | 0.036 | 0.030 |
BMI (Kg/m2) | 17.6 ± 2.7 | 21.7 ± 2.5 | < 0.001 | 26.1 ± 3.9 | < 0.001 | < 0.005 |
Family SES | ||||||
 1st tertile (poor), n (%) | 19 (47.5) | 8 (20.00) |  | 0 |  |  |
 2nd tertile (middle), n (%) | 13 (32.5) | 15 (37.5) |  | 3 |  |  |
 3rd tertile (rich), n (%) | 8 (20.00) | 17 (42.5) |  | 17 |  |  |
BCG vaccination status, n (%) | 23 (57.5) | 35 (87.5) | < 0.0025 | 18 (90.0) | 0.023 | 0.775 |
History of contact with active cases | 19 (54.3%) | 16 (45.7%) | 0.255 | – |  |  |
Duration of Symptom (days) | 61 (30, 105.5) | 75.5 (60, 121) | 0.087 | – |  |  |
Sputum smear results (AFB), n (%) | ||||||
 eAFB negative | 0 | 2 (5%) |  | – |  |  |
  1+ AFB | 9 (22.5%) | 10 (25.0%) |  | – |  |  |
  2+ AFB | 11 (27.5%) | 9 (22.5%) |  | – |  |  |
  3+ AFB | 20 (50.0%) | 19 (47.5%) |  | – |  |  |